Managing Obese Type 2 Diabetes with SUGALIFE-M: Why This Dual Therapy Works

Jul 23, 2025

Jul 23, 2025

Managing Obese Type 2 Diabetes Mellitus is more complex than it seems. With rising cases linked to sedentary lifestyles and poor dietary habits, effective treatment options are needed, especially ones that target both insulin resistance and impaired beta-cell function. This is where SUGALIFE-M plays a critical role.

What Is SUGALIFE-M?

Manufactured by Intra Life Pharma, SUGALIFE-M is a dual-action anti-diabetic tablet that combines Gliclazide 80mg with Metformin 500mg. This fixed-dose combination addresses hyperglycemia through complementary mechanisms:

Metformin improves insulin sensitivity and reduces hepatic glucose output.
Gliclazide stimulates insulin release from pancreatic beta cells.

Together, this formulation provides superior glycemic control in patients with obese Type 2 diabetes, especially those with secondary failure on sulfonylureas or metformin monotherapy.

This combination is produced by a reputable Gliclazide tablet manufacturer known for strict quality adherence and consistency across batches.

Why This Dual Therapy Works

Clinical evidence supports the efficacy of this fixed-dose combo:

Enhances fasting blood glucose levels
Reduces glycosylated hemoglobin (HbA1c)
Improves lipid profiles in diabetic patients
Offers better gastrointestinal tolerability compared to metformin alone

These benefits make SUGALIFE-M an excellent option for moderate to severe NIDDM and NIDDM with vascular complications. It's also a preferred choice by many Gliclazide tablet suppliers for institutional use due to its high tolerability.

When to Consider SUGALIFE-M

This combination is particularly effective in:

Obese patients struggling with poor glycemic control
Secondary failure cases of sulfonylurea or metformin alone
Individuals showing early signs of vascular issues due to diabetes

Prescribed once daily, the formulation is designed for long-term control and fewer side effects. This makes it ideal for diabetes management programs supplied by trusted Metformin tablet dealers.

Backed by Science

Several studies support the use of this combination therapy:

Indian J Endocrinol Metab. 2015 Mar-Apr, 20(2):195-198
Saudi Pharm J. 2018 Jan, 26(1):1–6
Am J Ther. 2010 Nov-Dec;17(6):559–565

These references confirm improved HbA1c control and lipid regulation with better patient compliance, making it a top pick for Gliclazide tablet exporters looking to offer advanced diabetic care options globally.

Why Intra Life Pharma?

Since 1981, Intra Life Pharma has been a trusted name among pharmaceutical manufacturing companies, offering over 2,500 formulations. Their investment in quality assurance, R&D, and distribution makes them a reliable Metformin tablet supplier for clinicians and pharmacies alike.